Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit
Maartje A. J. van den Broek, Steven W. M. Olde Damink, Bjorn Winkens, Christoph E. Broelsch, Massimo Malagó, Andreas Paul, Fuat H. Saner – 5 March 2010 – Clinically significant infections (CSIs) are life‐threatening but difficult to diagnose after liver transplantation (LTx). This study investigates the value of procalcitonin (PCT) in addition to c‐reactive protein (CRP) and the leukocyte count (LC) as a prognostic marker for CSIs in LTx recipients. The clinical course of 135 LTx recipients was prospectively studied.